Found: 44
Select item for more details and to access through your institution.
The multiple oral presentations of multiple myeloma.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 1, p. 259, doi. 10.1007/s00520-013-1960-y
- By:
- Publication type:
- Article
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
- By:
- Publication type:
- Article
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E455, doi. 10.1002/ajh.26360
- By:
- Publication type:
- Article
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. E319, doi. 10.1002/ajh.25633
- By:
- Publication type:
- Article
Long‐term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. E72, doi. 10.1002/ajh.25375
- By:
- Publication type:
- Article
Melphalan‐based autologous transplant in octogenarian multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. E2, doi. 10.1002/ajh.25310
- By:
- Publication type:
- Article
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 3, p. 272, doi. 10.1002/ajh.22273
- By:
- Publication type:
- Article
Thalidomidedexamethasone as primary therapy for advanced multiple myeloma.
- Published in:
- American Journal of Hematology, 2005, v. 79, n. 3, p. 194, doi. 10.1002/ajh.20382
- By:
- Publication type:
- Article
Transplantation in Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S48
- By:
- Publication type:
- Article
Primary treatment with 2-chiorodeoxyadenosine of low grade lymphomas that produce igg or IgA immunoglobulin.
- Published in:
- American Journal of Hematology, 1993, v. 43, n. 4, p. 326, doi. 10.1002/ajh.2830430425
- By:
- Publication type:
- Article
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I Trial of Vorinostat Combined With Bortezomib for the Treatment of Relapsing and/or Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 319, doi. 10.1016/j.clml.2012.07.007
- By:
- Publication type:
- Article
Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-κB activation.
- Published in:
- Modern Pathology, 2006, v. 19, n. 7, p. 891, doi. 10.1038/modpathol.3800609
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00973-w
- By:
- Publication type:
- Article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 5, p. 579, doi. 10.1111/j.1365-2141.2010.08533.x
- By:
- Publication type:
- Article
Monoclonal gammopathy of undetermined significance: a consensus statement.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 28, doi. 10.1111/j.1365-2141.2010.08207.x
- By:
- Publication type:
- Article
Recurrent Bleeding From a Duodenal Plasmacytoma Treated Successfully With Embolization of the Gastroduodenal Artery.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 6, p. 1691, doi. 10.1111/j.1572-0241.1999.01166.x
- By:
- Publication type:
- Article
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 4, p. 342, doi. 10.1111/ejh.12736
- By:
- Publication type:
- Article
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 426, doi. 10.1111/j.1600-0609.2009.01257.x
- By:
- Publication type:
- Article
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma.
- Published in:
- European Journal of Haematology, 2003, v. 71, n. 3, p. 174, doi. 10.1034/j.1600-0609.2003.00125.x
- By:
- Publication type:
- Article
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1663, doi. 10.1002/cncr.35171
- By:
- Publication type:
- Article
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1944, doi. 10.1111/bjh.19384
- By:
- Publication type:
- Article
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 866, doi. 10.1111/bjh.18944
- By:
- Publication type:
- Article
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. e37, doi. 10.1111/bjh.18753
- By:
- Publication type:
- Article
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide‐based maintenance therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. e23, doi. 10.1111/bjh.17393
- By:
- Publication type:
- Article
Gene expression profiling predicts relapse‐free and overall survival in newly diagnosed myeloma patients treated with novel therapies.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 4, p. e115, doi. 10.1111/bjh.17344
- By:
- Publication type:
- Article
Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 38, doi. 10.3816/CLML.2010.n.120
- By:
- Publication type:
- Article
Survival Disparities Between African American and Caucasian Patients With Multiple Myeloma Are Blunted in the Era of Novel Therapeutics and Autologous Stem Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E31, doi. 10.3816/CLML.2010.n.041
- By:
- Publication type:
- Article
Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Solitary plasmacytomas.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 19, p. 4468, doi. 10.1002/cncr.26031
- By:
- Publication type:
- Article
The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 16, p. 3807, doi. 10.1002/cncr.25139
- By:
- Publication type:
- Article
Cyclophosphamide desensitization in patients with severe hypersensitivity reactions to bendamustine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 982, doi. 10.1177/1078155219867127
- By:
- Publication type:
- Article
Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?
- Published in:
- Clinical Kidney Journal, 2015, v. 8, n. 4, p. 440, doi. 10.1093/ckj/sfv036
- By:
- Publication type:
- Article
Newly diagnosed multiple myeloma.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Prognostic features of asymptomatic multiple myeloma.
- Published in:
- British Journal of Haematology, 1997, v. 97, n. 4, p. 810, doi. 10.1046/j.1365-2141.1997.1122939.x
- By:
- Publication type:
- Article
Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Crystal-storing histiocytosis: a clinicopathological study of 13 cases.
- Published in:
- Histopathology, 2016, v. 68, n. 4, p. 482, doi. 10.1111/his.12768
- By:
- Publication type:
- Article